Cyclospora cayetanensis, a single-celled coccidian parasitic pathogen, causes intestinal infection resulting in diarrhea. In medical terminology, this diarrheal infection is referred as cyclospora infection (cyclosporiasis).
This report contains market size and forecasts of Cyclospora Diagnostic Testing in Global, including the following market information:
Global Cyclospora Diagnostic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cyclospora Diagnostic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acid-fast Staining Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cyclospora Diagnostic Testing include Thermo Fisher Scientific, Beckman Coulter, Inc, bioMerieux, Inc., CEPHEID, Diamedix Corporation, Hologic, Inc, Nanogen, Inc., Ortho Clinical Diagnostics (a Johnson & Johnson company) and DiaSorin S.p.A., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cyclospora Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cyclospora Diagnostic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cyclospora Diagnostic Testing Market Segment Percentages, by Type, 2021 (%)
Acid-fast Staining
Safranin Staining
Global Cyclospora Diagnostic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cyclospora Diagnostic Testing Market Segment Percentages, by Application, 2021 (%)
Commercial or Private Laboratories
Hospitals
Public Health Labs
Physician Offices
Global Cyclospora Diagnostic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cyclospora Diagnostic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cyclospora Diagnostic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cyclospora Diagnostic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Beckman Coulter, Inc
bioMerieux, Inc.
CEPHEID
Diamedix Corporation
Hologic, Inc
Nanogen, Inc.
Ortho Clinical Diagnostics (a Johnson & Johnson company)
DiaSorin S.p.A.
Roche Diagnostics (a division of Hoffmann-La Roche)
Siemens Healthcare
QIAGEN N.V.
Wako Chemicals USA, Inc.